To Have and Have Not: Intrinsic Platelet Hyperreactivity?

To Have and Have Not: Intrinsic Platelet Hyperreactivity?

Bibliographic Details
Main Authors:	Marc Laine, Corinne Frere, Laurent Bonello
Format:	Article
Language:	English
Published:	Wiley 2018-03-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	Editorials acute coronary syndrome antiplatelet platelet aggregation platelet reactivity
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.118.008750

Similar Items

Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment
by: Monica Verdoia, et al.
Published: (2019-10-01)

Antiplatelet Agents Have a Distinct Efficacy on Platelet Aggregation Induced by Infectious Bacteria
by: Nadji Hannachi, et al.
Published: (2020-06-01)

Platelet Hyperreactivity Related With COVID-19 Disease Severity
by: Merve Ergin Tuncay, et al.
Published: (2021-09-01)

A correlation study between mean platelet volume and platelet aggregation study in acute coronary syndrome patients
by: PT Navya, et al.
Published: (2024-07-01)

Platelet–Leukocyte Aggregate and Interleukin‐6: An Emerging Perspective on a New Diagnostic and Therapeutic Clue for Acute Coronary Syndrome, A Case–Control Study
by: Mohammad Ghorbani, et al.
Published: (2024-12-01)

Obstructive Sleep Apnea Affecting Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention
by: Xiao-Min Jiang, et al.
Published: (2018-01-01)

The Effectiveness of Antiplatelet Therapy and the Factors Influencing It in Patients with Acute Coronary Syndrome before and during the COVID-19 Pandemic
by: Ovidiu-Ionut Anchidin, et al.
Published: (2022-12-01)

Increased platelet reactivity and platelet–leukocyte aggregation after elective coronary bypass surgery
by: Torbjörn Ivert, et al.
Published: (2019-11-01)

Factors influencing platelet aggregation in patients with acute coronary syndrome
by: A V Mazurov, et al.
Published: (2014-09-01)

Clopidogrel versus ticagrelor in the treatment of Chinese patients undergoing percutaneous coronary intervention: effects on platelet function assessed by platelet function tests and mean platelet volume
by: Yang Zhang, et al.
Published: (2021-12-01)

ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS?
by: Yu. I. Grinshtein, et al.
Published: (2015-09-01)

THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY
by: D. A. Andreev
Published: (2015-09-01)

Systemic inflammatory status is associated with increased platelet reactivity in the early period after acute coronary syndromes
by: Stefano Cornara, et al.
Published: (2018-07-01)

Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation
by: Kai Jakobs, et al.
Published: (2022-03-01)

Novel antiplatelet targets in the treatment of acute coronary syndromes
by: Fawaz O. Alenazy, et al.
Published: (2021-01-01)

Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome
by: Charlotte Grosdidier, et al.
Published: (2019-10-01)

Mean platelet volume in acute coronary syndrome: Diagnostic implications
by: Gaveshna Gargi, et al.
Published: (2018-01-01)

Effect of indobufen vs. aspirin on platelet accumulation in patients with stable coronary heart disease after percutaneous coronary intervention: An open-label crossover study
by: Qiu-Ping Shi, et al.
Published: (2022-08-01)

Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome
by: Corinne Frere, et al.
Published: (2019-01-01)

Is Platelet Reactivity a Therapeutic Target to Limit Microvascular Obstruction?
by: Jaclyn Carberry, et al.
Published: (2022-02-01)

Exome-chip meta-analysis identifies association between variation in ANKRD26 and platelet aggregation
by: Ming-Huei Chen, et al.
Published: (2019-02-01)

Platelet reactivity in patients with chronic kidney disease undergoing percutaneous coronary intervention
by: Pei Zhu, et al.
Published: (2019-10-01)

Effects of novel quinoid thiosulfonate derivative on ADP-induced platelet aggregation
by: T. Halenova, et al.
Published: (2016-07-01)

Advances and Perspectives in methods for identifying high platelet reactivity
by: Hua Gao, et al.
Published: (2023-12-01)

Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults – a systematic review
by: Maren Meinshausen, et al.
Published: (2017-10-01)

Guided vs. conventional anti-platelet therapy for patients with acute coronary syndrome: A meta-analysis of randomized controlled trials
by: Peng-Yu Zhong, et al.
Published: (2023-03-01)

Platelet indices as markers of platelet turnover and aggregation: pathophysiological interpretation, clinical impact, perspectives in research
by: Malinova L.I., et al.
Published: (2017-12-01)

Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
by: Hamzah Khan, et al.
Published: (2021-12-01)

Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis
by: Lulu Dai, et al.
Published: (2022-06-01)

Aggregometry in the settings of thrombocytopenia, thrombocytosis and antiplatelet therapy
by: GianMarco Podda, et al.
Published: (2018-10-01)

Early clinical outcomes of surgical myocardial revascularization in patients with preoperative platelet dysfunction
by: Stojiljković Vladimir, et al.
Published: (2023-01-01)

Reticulated platelets – a new risk factor of atherothrombosis?
by: S. G. Khaspekova, et al.
Published: (2021-07-01)

Evaluation of laboratory effectiveness of clopidogrel after elective endovascular procedures in patients with the history of the new coronavirus infection (COVID-19)
by: Natalia V. Kuchkina, et al.
Published: (2021-10-01)

Antiplatelet efficacy of ticagrelor versus clopidogrel in Mediterranean patients with diabetes mellitus and chronic coronary syndromes: A crossover pharmacodynamic investigation
by: Ana Lucrecia Marcano, et al.
Published: (2022-11-01)

Lyophilized platelets inhibit platelet aggregation with simultaneous paradoxical promotion of platelet adhesion
by: Brian Schnoor, et al.
Published: (2022-08-01)

Platelet phenotypes and practical aspects of platelet function testing in cardiology
by: Zh. D. Kobalava, et al.
Published: (2023-12-01)

High platelet adrenergic activity and concomitant activation of the pituitary/medullar axis as alarming laboratory parameters in ACS survivors—the STRESS-AMI study
by: Zalán Gulyás, et al.
Published: (2024-02-01)

Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short?
by: Philipp Mourikis, et al.
Published: (2023-01-01)

Platelet Function, Platelet Size and Content of Reticulated Platelets: Interactions in Patients Receiving Dual Antiplatelet Therapy
by: Valeria V. Bodrova, et al.
Published: (2024-10-01)

Platelet reactivity in dyslipidemia: atherothrombotic signaling and therapeutic implications
by: Moua Yang, et al.
Published: (2021-03-01)